Olinvacimab (Anti-VEGFR2 / KDR / CD309)Olinvacimab (Anti-VEGFR2 / KDR / CD309)
Move your mouse over image or click to enlarge

Olinvacimab (Anti-VEGFR2 / KDR / CD309)

Olinvacimab (Anti-VEGFR2 / KDR / CD309) is a fully human monoclonal antibody targeting VEGFR2. It has antiangiogenic activity and can be used for the research of recurrent glioblastoma and breast cancer. MW :146.88 KD
Cat# Size Price Qty Buy
A2979-1mg*25 1mg*25
£3,415.00
A2979-1mg*5 1mg*5
£1,138.00
A2979-1mg 1mg
£384.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2979

Related Documents